| 43.50 |  +0.46 / +1.07% |
Data as of 4:01pm ET | Day’s Change |
| 43.50 |  0.00 / 0.00% |
Volume: 78.7K |
| Here's What This $5 Billion Hedge Fund Has Been Buying 1:06am / MotleyFool.com | Generic drugs: Watchdogs probe pay-for-delay deals May 28 / FT.com |
| Revlimid Gains, Celgene Loses Jun 05 / MotleyFool.com | Biogen Submits Plegridy BLA - Analyst Blog May 23 / Zacks.com |
| Abbott Labs' HPV Test in Canada - Analyst Blog May 31 / Zacks.com | US doctors paid $1bn by top drug companies May 22 / FT.com |
| Good News for Roche - Analyst Blog May 30 / Zacks.com | Excerpt From My Daily Journal Entry May 20 / StockTwits |
| Gilead's Stribild Approved in the EU - Analyst Blog May 29 / Zacks.com |
| Previous close | 43.04 |
| Today’s open | 42.91 |
| Day’s range | 42.65 - 43.57 |
| Volume | 4,093,076 |
| Average volume (3 months) | 6,508,170 |
| Market cap | $68.2B |
| Dividend yield | 3.68% |
| Earnings growth (last year) | +54.24% |
| Earnings growth (this year) | -6.86% |
| Earnings growth (next 5 years) | +5.00% |
| Revenue growth (last year) | +5.37% |
| P/E ratio | 11.0 |
| Price/Sales | 2.93 |
| Price/Book | 20.18 |
| Today’s change | Today’s % change | |
|---|---|---|
| NVONovo Nordisk A/S | +1.23 | +0.75% |
| AZNAstraZeneca PLC | +0.69 | +1.36% |
| BMYBristol-Myers Squibb... | +0.83 | +1.80% |
| LLYEli Lilly and Co | +0.28 | +0.54% |
| Next reporting date | August 28, 2013 |
| EPS forecast (this quarter) | $0.79 |
| Annual revenue (last year) | $18.4B |
| Annual profit (last year) | $5.3B |
| Net profit margin | 28.70% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chairman & Chief Executive Officer Richard A. Gonzalez |
Senior Vice President- Operations Azita Saleki-Gerhardt, PhD |
Corporate headquarters North Chicago, Illinois |
.
